Literature DB >> 12645860

Long-term follow-up and prognosis of chronic granulomatous disease in Yugoslavia: is there a role for early bone marrow transplantation?

Srdjan Pasic1, Aleksandra Minic, Predrag Minic, Dobrila Veljkovic, Desa Lilic, Bojana Slavkovic, Nada Pejnovic, Mario Abinun.   

Abstract

We report the long-term follow-up of 12 pediatric-aged patients with chronic granulomatous disease (CGD). The mean age at the onset of infections was 5 months with a median delay in diagnosis of 2.5 years. Bacille Calmette-Guérin lymphadenitis was the most common presenting infection (6) followed by suppurative lymphadenitis (4), liver abscess (1), or Salmonella sepsis (1). Prophylaxis with cotrimoxazole was recommended to all patients. During the mean follow-up of 10 years (range, 4-23 years) pneumonitis was the most prevalent infection (91%) followed by lymphadenitis (83%), aphtous stomatitis (58%), and liver abscesses (25%). Seven (58%) patients developed chronic lung disease due to grossly delayed diagnosis (3) or poor compliance with antimicrobial prophylaxis (4). Five (41%) patients died during the second decade of life of aspergillosis (3) or chronic lung disease (2). Probability of survival into the third decade of life was estimated to be only 19%. We argue that HLA-identical bone marrow transplantation (BMT), if possible, should be attempted at early age because of significant morbidity and mortality in adolescence. BMT also should be considered in patients who suffer severe infections despite antimicrobial prophylaxis or patients with evidence of chronic lung disease. Possibility of elective BMT from unrelated donors remains to be carefully evaluated.

Entities:  

Mesh:

Year:  2003        PMID: 12645860     DOI: 10.1023/a:1021952315651

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  38 in total

1.  Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years.

Authors:  A S Grumach; A J Duarte; R Bellinati-Pires; A C Pastorino; C M Jacob; C L Diogo; A Condino-Neto; M Kirschfink; M M Carneiro-Sampaio
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Aspergillus osteomyelitis in chronic granulomatous disease: treatment with recombinant gamma-interferon and itraconazole.

Authors:  S Pasic; M Abinun; B Pistignjat; B Vlajic; J Rakic; L Sarjanovic; N Ostojic
Journal:  Pediatr Infect Dis J       Date:  1996-09       Impact factor: 2.129

3.  Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up.

Authors:  N Kamani; C S August; D E Campbell; N F Hassan; S D Douglas
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

4.  Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome.

Authors:  T M Eppinger; P A Greenberger; D A White; A E Brown; C Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

5.  Immunological conditions of children with BCG disseminated infection.

Authors:  J L Casanova; E Jouanguy; S Lamhamedi; S Blanche; A Fischer
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

6.  Successful unrelated bone marrow transplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis.

Authors:  C Watanabe; S Yajima; T Taguchi; K Toya; Y Fujii; T Hongo; T Ohzeki
Journal:  Bone Marrow Transplant       Date:  2001-07       Impact factor: 5.483

7.  Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

Authors:  J Liese; S Kloos; V Jendrossek; T Petropoulou; U Wintergerst; G Notheis; M Gahr; B H Belohradsky
Journal:  J Pediatr       Date:  2000-11       Impact factor: 4.406

Review 8.  Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease.

Authors:  C M Ho; M R Vowels; L Lockwood; J B Ziegler
Journal:  Bone Marrow Transplant       Date:  1996-07       Impact factor: 5.483

9.  Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.

Authors:  H Ozsahin; M von Planta; I Müller; H C Steinert; D Nadal; R Lauener; P Tuchschmid; U V Willi; M Ozsahin; N E Crompton; R A Seger
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

10.  Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency.

Authors:  A Fischer; P Landais; W Friedrich; B Gerritsen; A Fasth; F Porta; A Vellodi; M Benkerrou; J P Jais; M Cavazzana-Calvo
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

View more
  1 in total

1.  Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan.

Authors:  Shinichi Kobayashi; Shizuko Murayama; Sayaka Takanashi; Kumiko Takahashi; Sachiko Miyatsuka; Tomoko Fujita; Sadato Ichinohe; Yuichi Koike; Toshitaka Kohagizawa; Hirosumi Mori; Yasushi Deguchi; Kaoru Higuchi; Hiroaki Wakasugi; Tatsuya Sato; Yasuyuki Wada; Masato Nagata; Nobuhiko Okabe; Osamu Tatsuzawa
Journal:  Eur J Pediatr       Date:  2008-03-12       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.